Clinical Trials Logo
  1. Home
  2. Fungal Infections
  3. NCT01782131

A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)

Invasive Pulmonary Aspergillosis Clinical Trial

Official title:
A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults and Adolescents (Phase 3; Protocol No. MK-5592-069)

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of posaconazole (POS) versus voriconazole (VOR) in the treatment of adults and adolescents with invasive aspergillosis (IA). The primary hypothesis is that the all-cause mortality through Day 42 in the POS treatment group is non-inferior to that in the VOR treatment group.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01782131
Study type Interventional
Source Merck Sharp & Dohme LLC
Contact
Status Completed
Phase Phase 3
Start date September 25, 2013
Completion date September 10, 2019
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05138666 - Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions. N/A
Not yet recruiting NCT02234739 - Voriconazole for IPA in Chinese Patients With COPD Phase 4
Completed NCT01615809 - Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia Phase 2
Completed NCT04267497 - Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) Phase 1
Recruiting NCT05860387 - Early Diagnosis of Invasive Lung Aspergillosis
Withdrawn NCT01188759 - Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects Phase 3
Completed NCT00923832 - Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis N/A
Recruiting NCT05982912 - VOC in Breath Samples for the Diagnosis of IPA
Not yet recruiting NCT02100761 - CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients N/A
Recruiting NCT00986713 - Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation Phase 4
Recruiting NCT05569824 - LFD of Aspergillus Antigen in Paediatrics
Not yet recruiting NCT04848831 - Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid
Completed NCT04077697 - Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
Completed NCT03672292 - Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis Phase 2
Recruiting NCT01499433 - Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Phase 4
Completed NCT01247142 - Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis N/A
Completed NCT00501098 - Prophylaxis of Fungal Invasive Infections in Leukemia Phase 2
Recruiting NCT03748069 - Influenza Associated Aspergillosis In-depth Investigation
Completed NCT02058316 - Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
Terminated NCT03327727 - VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults Phase 2